▶ 調査レポート

エレクトロコンピテントセルの世界市場 2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Electrocompetent Cells Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。エレクトロコンピテントセルの世界市場 2020年:企業別、地域別、種類・用途別 / Global Electrocompetent Cells Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D005-00345資料のイメージです。• レポートコード:D005-00345
• 出版社/出版日:GlobalInfoResearch / 2020年5月29日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、120ページ
• 納品方法:Eメール
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、エレクトロコンピテントセルの世界市場を広く調査・分析し、今後の市場展望をまとめております。エレクトロコンピテントセルの種類別市場規模(クローンコンピテントセル、アグロバクテリウムツメファシエンスコンピテントセル、発現コンピテントセル)、用途別市場規模(サブクローニング&ルーチンクローニング、ファージディスプレイライブラリー構築、有毒/不安定なDnaクローニング、ハイスループットクローニング、タンパク質発現、変異誘発、一本鎖Dna産生、バクミドの作成、Cre-lox組換え(PIR1 / PIR2))、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Merck KGaA、Yeastern Biotech、Takara Bio、Thermo Fisher Scientific、GeneScript Corporation、Agilent Technologies、QIAGEN N.V.、Beijing TransGen Biotech、Promega Corporation、New England Biolabs、Bioline、Cell Applications、OriGene Technologies、Scarab Genomics、Delphi Genetics、Bio-Rad Laboratories、Lucigen、BioDynamics Laboratory、IBA GmBH、Zymo Research
・地域別グローバル市場分析 2015年-2020年
・エレクトロコンピテントセルの北米市場(アメリカ、カナダ、メキシコ)
・エレクトロコンピテントセルのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・エレクトロコンピテントセルのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・エレクトロコンピテントセルの南米市場(ブラジル、アルゼンチン)
・エレクトロコンピテントセルの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:クローンコンピテントセル、アグロバクテリウムツメファシエンスコンピテントセル、発現コンピテントセル
・用途別分析:サブクローニング&ルーチンクローニング、ファージディスプレイライブラリー構築、有毒/不安定なDnaクローニング、ハイスループットクローニング、タンパク質発現、変異誘発、一本鎖Dna産生、バクミドの作成、Cre-lox組換え(PIR1 / PIR2)
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Electrocompetent Cells market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Electrocompetent Cells market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Electrocompetent Cells market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Electrocompetent Cells market has been segmented into:
Cloned Competent Cells
Agrobacterium tumefaciens Competent Cells
Expression Competent Cells

By Application, Electrocompetent Cells has been segmented into:
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable Dna Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded Dna Production
Bacmid creation
Cre-lox recombination (PIR1/PIR2)

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Electrocompetent Cells market presented in the report. This section sheds light on the sales growth of different regional and country-level Electrocompetent Cells markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Electrocompetent Cells market.

The report offers in-depth assessment of the growth and other aspects of the Electrocompetent Cells market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Electrocompetent Cells Market Share Analysis
Electrocompetent Cells competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Electrocompetent Cells sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Electrocompetent Cells sales, revenue and market share for each player covered in this report.

The major players covered in Electrocompetent Cells are:
Merck KGaA
Yeastern Biotech
Takara Bio
Thermo Fisher Scientific
GeneScript Corporation
Agilent Technologies
QIAGEN N.V.
Beijing TransGen Biotech
Promega Corporation
New England Biolabs
Bioline
Cell Applications
OriGene Technologies
Scarab Genomics
Delphi Genetics
Bio-Rad Laboratories
Lucigen
BioDynamics Laboratory
IBA GmBH
Zymo Research

レポート目次

Table of Contents

1 Electrocompetent Cells Market Overview
1.1 Product Overview and Scope of Electrocompetent Cells
1.2 Classification of Electrocompetent Cells by Type
1.2.1 Global Electrocompetent Cells Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Electrocompetent Cells Revenue Market Share by Type in 2019
1.2.3 Cloned Competent Cells
1.2.4 Agrobacterium tumefaciens Competent Cells
1.2.5 Expression Competent Cells
1.3 Global Electrocompetent Cells Market by Application
1.3.1 Overview: Global Electrocompetent Cells Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Subcloning & Routine Cloning
1.3.3 Phage Display Library Construction
1.3.4 Toxic/Unstable Dna Cloning
1.3.5 High-Throughput Cloning
1.3.6 Protein Expression
1.3.7 Mutagenesis
1.3.8 Single-Stranded Dna Production
1.3.9 Bacmid creation
1.3.10 Cre-lox recombination (PIR1/PIR2)
1.4 Global Electrocompetent Cells Market by Regions
1.4.1 Global Electrocompetent Cells Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Electrocompetent Cells (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Electrocompetent Cells Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Electrocompetent Cells Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Electrocompetent Cells Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Electrocompetent Cells Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Electrocompetent Cells Status and Prospect (2015-2025)
2 Company Profiles
2.1 Merck KGaA
2.1.1 Merck KGaA Details
2.1.2 Merck KGaA Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck KGaA SWOT Analysis
2.1.4 Merck KGaA Product and Services
2.1.5 Merck KGaA Electrocompetent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.2 Yeastern Biotech
2.2.1 Yeastern Biotech Details
2.2.2 Yeastern Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Yeastern Biotech SWOT Analysis
2.2.4 Yeastern Biotech Product and Services
2.2.5 Yeastern Biotech Electrocompetent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.3 Takara Bio
2.3.1 Takara Bio Details
2.3.2 Takara Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Takara Bio SWOT Analysis
2.3.4 Takara Bio Product and Services
2.3.5 Takara Bio Electrocompetent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Thermo Fisher Scientific SWOT Analysis
2.4.4 Thermo Fisher Scientific Product and Services
2.4.5 Thermo Fisher Scientific Electrocompetent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.5 GeneScript Corporation
2.5.1 GeneScript Corporation Details
2.5.2 GeneScript Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GeneScript Corporation SWOT Analysis
2.5.4 GeneScript Corporation Product and Services
2.5.5 GeneScript Corporation Electrocompetent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.6 Agilent Technologies
2.6.1 Agilent Technologies Details
2.6.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Agilent Technologies SWOT Analysis
2.6.4 Agilent Technologies Product and Services
2.6.5 Agilent Technologies Electrocompetent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.7 QIAGEN N.V.
2.7.1 QIAGEN N.V. Details
2.7.2 QIAGEN N.V. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 QIAGEN N.V. SWOT Analysis
2.7.4 QIAGEN N.V. Product and Services
2.7.5 QIAGEN N.V. Electrocompetent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.8 Beijing TransGen Biotech
2.8.1 Beijing TransGen Biotech Details
2.8.2 Beijing TransGen Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Beijing TransGen Biotech SWOT Analysis
2.8.4 Beijing TransGen Biotech Product and Services
2.8.5 Beijing TransGen Biotech Electrocompetent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.9 Promega Corporation
2.9.1 Promega Corporation Details
2.9.2 Promega Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Promega Corporation SWOT Analysis
2.9.4 Promega Corporation Product and Services
2.9.5 Promega Corporation Electrocompetent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.10 New England Biolabs
2.10.1 New England Biolabs Details
2.10.2 New England Biolabs Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 New England Biolabs SWOT Analysis
2.10.4 New England Biolabs Product and Services
2.10.5 New England Biolabs Electrocompetent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.11 Bioline
2.11.1 Bioline Details
2.11.2 Bioline Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Bioline SWOT Analysis
2.11.4 Bioline Product and Services
2.11.5 Bioline Electrocompetent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.12 Cell Applications
2.12.1 Cell Applications Details
2.12.2 Cell Applications Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Cell Applications SWOT Analysis
2.12.4 Cell Applications Product and Services
2.12.5 Cell Applications Electrocompetent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.13 OriGene Technologies
2.13.1 OriGene Technologies Details
2.13.2 OriGene Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 OriGene Technologies SWOT Analysis
2.13.4 OriGene Technologies Product and Services
2.13.5 OriGene Technologies Electrocompetent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.14 Scarab Genomics
2.14.1 Scarab Genomics Details
2.14.2 Scarab Genomics Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Scarab Genomics SWOT Analysis
2.14.4 Scarab Genomics Product and Services
2.14.5 Scarab Genomics Electrocompetent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.15 Delphi Genetics
2.15.1 Delphi Genetics Details
2.15.2 Delphi Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Delphi Genetics SWOT Analysis
2.15.4 Delphi Genetics Product and Services
2.15.5 Delphi Genetics Electrocompetent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.16 Bio-Rad Laboratories
2.16.1 Bio-Rad Laboratories Details
2.16.2 Bio-Rad Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Bio-Rad Laboratories SWOT Analysis
2.16.4 Bio-Rad Laboratories Product and Services
2.16.5 Bio-Rad Laboratories Electrocompetent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.17 Lucigen
2.17.1 Lucigen Details
2.17.2 Lucigen Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Lucigen SWOT Analysis
2.17.4 Lucigen Product and Services
2.17.5 Lucigen Electrocompetent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.18 BioDynamics Laboratory
2.18.1 BioDynamics Laboratory Details
2.18.2 BioDynamics Laboratory Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 BioDynamics Laboratory SWOT Analysis
2.18.4 BioDynamics Laboratory Product and Services
2.18.3 BioDynamics Laboratory Electrocompetent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.19 IBA GmBH
2.19.1 IBA GmBH Details
2.19.2 IBA GmBH Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 IBA GmBH SWOT Analysis
2.19.4 IBA GmBH Product and Services
2.19.5 IBA GmBH Electrocompetent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.20 Zymo Research
2.20.1 Zymo Research Details
2.20.2 Zymo Research Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Zymo Research SWOT Analysis
2.20.4 Zymo Research Product and Services
2.20.5 Zymo Research Electrocompetent Cells Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Electrocompetent Cells Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Electrocompetent Cells Players Market Share
3.2.2 Top 10 Electrocompetent Cells Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Electrocompetent Cells Revenue and Market Share by Regions
4.2 North America Electrocompetent Cells Revenue and Growth Rate (2015-2020)
4.3 Europe Electrocompetent Cells Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Electrocompetent Cells Revenue and Growth Rate (2015-2020)
4.5 South America Electrocompetent Cells Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Electrocompetent Cells Revenue and Growth Rate (2015-2020)
5 North America Electrocompetent Cells Revenue by Countries
5.1 North America Electrocompetent Cells Revenue by Countries (2015-2020)
5.2 USA Electrocompetent Cells Revenue and Growth Rate (2015-2020)
5.3 Canada Electrocompetent Cells Revenue and Growth Rate (2015-2020)
5.4 Mexico Electrocompetent Cells Revenue and Growth Rate (2015-2020)
6 Europe Electrocompetent Cells Revenue by Countries
6.1 Europe Electrocompetent Cells Revenue by Countries (2015-2020)
6.2 Germany Electrocompetent Cells Revenue and Growth Rate (2015-2020)
6.3 UK Electrocompetent Cells Revenue and Growth Rate (2015-2020)
6.4 France Electrocompetent Cells Revenue and Growth Rate (2015-2020)
6.5 Russia Electrocompetent Cells Revenue and Growth Rate (2015-2020)
6.6 Italy Electrocompetent Cells Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Electrocompetent Cells Revenue by Countries
7.1 Asia-Pacific Electrocompetent Cells Revenue by Countries (2015-2020)
7.2 China Electrocompetent Cells Revenue and Growth Rate (2015-2020)
7.3 Japan Electrocompetent Cells Revenue and Growth Rate (2015-2020)
7.4 Korea Electrocompetent Cells Revenue and Growth Rate (2015-2020)
7.5 India Electrocompetent Cells Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Electrocompetent Cells Revenue and Growth Rate (2015-2020)
8 South America Electrocompetent Cells Revenue by Countries
8.1 South America Electrocompetent Cells Revenue by Countries (2015-2020)
8.2 Brazil Electrocompetent Cells Revenue and Growth Rate (2015-2020)
8.3 Argentina Electrocompetent Cells Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Electrocompetent Cells by Countries
9.1 Middle East & Africa Electrocompetent Cells Revenue by Countries (2015-2020)
9.2 Saudi Arabia Electrocompetent Cells Revenue and Growth Rate (2015-2020)
9.3 UAE Electrocompetent Cells Revenue and Growth Rate (2015-2020)
9.4 Egypt Electrocompetent Cells Revenue and Growth Rate (2015-2020)
9.5 South Africa Electrocompetent Cells Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Electrocompetent Cells Revenue and Market Share by Type (2015-2020)
10.2 Global Electrocompetent Cells Market Forecast by Type (2019-2024)
10.3 Cloned Competent Cells Revenue Growth Rate (2015-2025)
10.4 Agrobacterium tumefaciens Competent Cells Revenue Growth Rate (2015-2025)
10.5 Expression Competent Cells Revenue Growth Rate (2015-2025)
11 Global Electrocompetent Cells Market Segment by Application
11.1 Global Electrocompetent Cells Revenue Market Share by Application (2015-2020)
11.2 Electrocompetent Cells Market Forecast by Application (2019-2024)
11.3 Subcloning & Routine Cloning Revenue Growth (2015-2020)
11.4 Phage Display Library Construction Revenue Growth (2015-2020)
11.5 Toxic/Unstable Dna Cloning Revenue Growth (2015-2020)
11.6 High-Throughput Cloning Revenue Growth (2015-2020)
11.7 Protein Expression Revenue Growth (2015-2020)
11.8 Mutagenesis Revenue Growth (2015-2020)
11.9 Single-Stranded Dna Production Revenue Growth (2015-2020)
11.10 Bacmid creation Revenue Growth (2015-2020)
11.11 Cre-lox recombination (PIR1/PIR2) Revenue Growth (2015-2020)
12 Global Electrocompetent Cells Market Size Forecast (2021-2025)
12.1 Global Electrocompetent Cells Market Size Forecast (2021-2025)
12.2 Global Electrocompetent Cells Market Forecast by Regions (2021-2025)
12.3 North America Electrocompetent Cells Revenue Market Forecast (2021-2025)
12.4 Europe Electrocompetent Cells Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Electrocompetent Cells Revenue Market Forecast (2021-2025)
12.6 South America Electrocompetent Cells Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Electrocompetent Cells Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Electrocompetent Cells Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Electrocompetent Cells by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Electrocompetent Cells Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Electrocompetent Cells Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Merck KGaA Corporate Information, Location and Competitors
Table 6. Merck KGaA Electrocompetent Cells Major Business
Table 7. Merck KGaA Electrocompetent Cells Total Revenue (USD Million) (2017-2018)
Table 8. Merck KGaA SWOT Analysis
Table 9. Merck KGaA Electrocompetent Cells Product and Solutions
Table 10. Merck KGaA Electrocompetent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Yeastern Biotech Corporate Information, Location and Competitors
Table 12. Yeastern Biotech Electrocompetent Cells Major Business
Table 13. Yeastern Biotech Electrocompetent Cells Total Revenue (USD Million) (2018-2019)
Table 14. Yeastern Biotech SWOT Analysis
Table 15. Yeastern Biotech Electrocompetent Cells Product and Solutions
Table 16. Yeastern Biotech Electrocompetent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Takara Bio Corporate Information, Location and Competitors
Table 18. Takara Bio Electrocompetent Cells Major Business
Table 19. Takara Bio Electrocompetent Cells Total Revenue (USD Million) (2017-2018)
Table 20. Takara Bio SWOT Analysis
Table 21. Takara Bio Electrocompetent Cells Product and Solutions
Table 22. Takara Bio Electrocompetent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 24. Thermo Fisher Scientific Electrocompetent Cells Major Business
Table 25. Thermo Fisher Scientific Electrocompetent Cells Total Revenue (USD Million) (2017-2018)
Table 26. Thermo Fisher Scientific SWOT Analysis
Table 27. Thermo Fisher Scientific Electrocompetent Cells Product and Solutions
Table 28. Thermo Fisher Scientific Electrocompetent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. GeneScript Corporation Corporate Information, Location and Competitors
Table 30. GeneScript Corporation Electrocompetent Cells Major Business
Table 31. GeneScript Corporation Electrocompetent Cells Total Revenue (USD Million) (2017-2018)
Table 32. GeneScript Corporation SWOT Analysis
Table 33. GeneScript Corporation Electrocompetent Cells Product and Solutions
Table 34. GeneScript Corporation Electrocompetent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Agilent Technologies Corporate Information, Location and Competitors
Table 36. Agilent Technologies Electrocompetent Cells Major Business
Table 37. Agilent Technologies Electrocompetent Cells Total Revenue (USD Million) (2017-2018)
Table 38. Agilent Technologies SWOT Analysis
Table 39. Agilent Technologies Electrocompetent Cells Product and Solutions
Table 40. Agilent Technologies Electrocompetent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. QIAGEN N.V. Corporate Information, Location and Competitors
Table 42. QIAGEN N.V. Electrocompetent Cells Major Business
Table 43. QIAGEN N.V. Electrocompetent Cells Total Revenue (USD Million) (2017-2018)
Table 44. QIAGEN N.V. SWOT Analysis
Table 45. QIAGEN N.V. Electrocompetent Cells Product and Solutions
Table 46. QIAGEN N.V. Electrocompetent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Beijing TransGen Biotech Corporate Information, Location and Competitors
Table 48. Beijing TransGen Biotech Electrocompetent Cells Major Business
Table 49. Beijing TransGen Biotech Electrocompetent Cells Total Revenue (USD Million) (2017-2018)
Table 50. Beijing TransGen Biotech SWOT Analysis
Table 51. Beijing TransGen Biotech Electrocompetent Cells Product and Solutions
Table 52. Beijing TransGen Biotech Electrocompetent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Promega Corporation Corporate Information, Location and Competitors
Table 54. Promega Corporation Electrocompetent Cells Major Business
Table 55. Promega Corporation Electrocompetent Cells Total Revenue (USD Million) (2017-2018)
Table 56. Promega Corporation SWOT Analysis
Table 57. Promega Corporation Electrocompetent Cells Product and Solutions
Table 58. Promega Corporation Electrocompetent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. New England Biolabs Corporate Information, Location and Competitors
Table 60. New England Biolabs Electrocompetent Cells Major Business
Table 61. New England Biolabs Electrocompetent Cells Total Revenue (USD Million) (2017-2018)
Table 62. New England Biolabs SWOT Analysis
Table 63. New England Biolabs Electrocompetent Cells Product and Solutions
Table 64. New England Biolabs Electrocompetent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Bioline Corporate Information, Location and Competitors
Table 66. Bioline Electrocompetent Cells Major Business
Table 67. Bioline Electrocompetent Cells Total Revenue (USD Million) (2017-2018)
Table 68. Bioline SWOT Analysis
Table 69. Bioline Electrocompetent Cells Product and Solutions
Table 70. Bioline Electrocompetent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Cell Applications Corporate Information, Location and Competitors
Table 72. Cell Applications Electrocompetent Cells Major Business
Table 73. Cell Applications Electrocompetent Cells Total Revenue (USD Million) (2017-2018)
Table 74. Cell Applications SWOT Analysis
Table 75. Cell Applications Electrocompetent Cells Product and Solutions
Table 76. Cell Applications Electrocompetent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. OriGene Technologies Corporate Information, Location and Competitors
Table 78. OriGene Technologies Electrocompetent Cells Major Business
Table 79. OriGene Technologies Electrocompetent Cells Total Revenue (USD Million) (2017-2018)
Table 80. OriGene Technologies SWOT Analysis
Table 81. OriGene Technologies Electrocompetent Cells Product and Solutions
Table 82. OriGene Technologies Electrocompetent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Scarab Genomics Corporate Information, Location and Competitors
Table 84. Scarab Genomics Electrocompetent Cells Major Business
Table 85. Scarab Genomics Electrocompetent Cells Total Revenue (USD Million) (2017-2018)
Table 86. Scarab Genomics SWOT Analysis
Table 87. Scarab Genomics Electrocompetent Cells Product and Solutions
Table 88. Scarab Genomics Electrocompetent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Delphi Genetics Corporate Information, Location and Competitors
Table 90. Delphi Genetics Electrocompetent Cells Major Business
Table 91. Delphi Genetics Electrocompetent Cells Total Revenue (USD Million) (2017-2018)
Table 92. Delphi Genetics SWOT Analysis
Table 93. Delphi Genetics Electrocompetent Cells Product and Solutions
Table 94. Delphi Genetics Electrocompetent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Bio-Rad Laboratories Corporate Information, Location and Competitors
Table 96. Bio-Rad Laboratories Electrocompetent Cells Major Business
Table 97. Bio-Rad Laboratories Electrocompetent Cells Total Revenue (USD Million) (2017-2018)
Table 98. Bio-Rad Laboratories SWOT Analysis
Table 99. Bio-Rad Laboratories Electrocompetent Cells Product and Solutions
Table 100. Bio-Rad Laboratories Electrocompetent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Lucigen Corporate Information, Location and Competitors
Table 102. Lucigen Electrocompetent Cells Major Business
Table 103. Lucigen Electrocompetent Cells Total Revenue (USD Million) (2017-2018)
Table 104. Lucigen SWOT Analysis
Table 105. Lucigen Electrocompetent Cells Product and Solutions
Table 106. Lucigen Electrocompetent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. BioDynamics Laboratory Electrocompetent Cells Type and Application
Table 108. BioDynamics Laboratory Electrocompetent Cells Major Business
Table 109. BioDynamics Laboratory Electrocompetent Cells Total Revenue (USD Million) (2017-2018)
Table 110. BioDynamics Laboratory SWOT Analysis
Table 111. BioDynamics Laboratory Electrocompetent Cells Product and Solutions
Table 112. BioDynamics Laboratory Electrocompetent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. IBA GmBH Corporate Information, Location and Competitors
Table 114. IBA GmBH Electrocompetent Cells Major Business
Table 115. IBA GmBH Electrocompetent Cells Total Revenue (USD Million) (2017-2018)
Table 116. IBA GmBH SWOT Analysis
Table 117. IBA GmBH Electrocompetent Cells Product and Solutions
Table 118. IBA GmBH Electrocompetent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. Zymo Research Corporate Information, Location and Competitors
Table 120. Zymo Research Electrocompetent Cells Major Business
Table 121. Zymo Research Electrocompetent Cells Total Revenue (USD Million) (2017-2018)
Table 122. Zymo Research SWOT Analysis
Table 123. Zymo Research Electrocompetent Cells Product and Solutions
Table 124. Zymo Research Electrocompetent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 125. Global Electrocompetent Cells Revenue (Million USD) by Players (2015-2020)
Table 126. Global Electrocompetent Cells Revenue Share by Players (2015-2020)
Table 127. Global Electrocompetent Cells Revenue (Million USD) by Regions (2015-2020)
Table 128. Global Electrocompetent Cells Revenue Market Share by Regions (2015-2020)
Table 129. North America Electrocompetent Cells Revenue by Countries (2015-2020)
Table 130. North America Electrocompetent Cells Revenue Market Share by Countries (2015-2020)
Table 131. Europe Electrocompetent Cells Revenue (Million USD) by Countries (2015-2020)
Table 132. Asia-Pacific Electrocompetent Cells Revenue (Million USD) by Countries (2015-2020)
Table 133. South America Electrocompetent Cells Revenue by Countries (2015-2020)
Table 134. South America Electrocompetent Cells Revenue Market Share by Countries (2015-2020)
Table 135. Middle East and Africa Electrocompetent Cells Revenue (Million USD) by Countries (2015-2020)
Table 136. Middle East and Africa Electrocompetent Cells Revenue Market Share by Countries (2015-2020)
Table 137. Global Electrocompetent Cells Revenue (Million USD) by Type (2015-2020)
Table 138. Global Electrocompetent Cells Revenue Share by Type (2015-2020)
Table 139. Global Electrocompetent Cells Revenue Forecast by Type (2021-2025)
Table 140. Global Electrocompetent Cells Revenue by Application (2015-2020)
Table 141. Global Electrocompetent Cells Revenue Share by Application (2015-2020)
Table 142. Global Electrocompetent Cells Revenue Forecast by Application (2021-2025)
Table 143. Global Electrocompetent Cells Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Electrocompetent Cells Picture
Figure 2. Global Electrocompetent Cells Revenue Market Share by Type in 2019
Figure 3. Cloned Competent Cells Picture
Figure 4. Agrobacterium tumefaciens Competent Cells Picture
Figure 5. Expression Competent Cells Picture
Figure 6. Electrocompetent Cells Revenue Market Share by Application in 2019
Figure 7. Subcloning & Routine Cloning Picture
Figure 8. Phage Display Library Construction Picture
Figure 9. Toxic/Unstable Dna Cloning Picture
Figure 10. High-Throughput Cloning Picture
Figure 11. Protein Expression Picture
Figure 12. Mutagenesis Picture
Figure 13. Single-Stranded Dna Production Picture
Figure 14. Bacmid creation Picture
Figure 15. Cre-lox recombination (PIR1/PIR2) Picture
Figure 16. Global Electrocompetent Cells Revenue (USD Million) and Growth Rate (2015-2025)
Figure 17. North America Electrocompetent Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Europe Electrocompetent Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Asia-Pacific Electrocompetent Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. South America Electrocompetent Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Middle East and Africa Electrocompetent Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Electrocompetent Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Global Electrocompetent Cells Revenue Share by Players in 2019
Figure 24. Global Top 5 Players Electrocompetent Cells Revenue Market Share in 2019
Figure 25. Global Top 10 Players Electrocompetent Cells Revenue Market Share in 2019
Figure 26. Key Players Market Share Trend
Figure 27. Global Electrocompetent Cells Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 28. Global Electrocompetent Cells Revenue Market Share by Regions (2015-2020)
Figure 29. Global Electrocompetent Cells Revenue Market Share by Regions in 2018
Figure 30. North America Electrocompetent Cells Revenue and Growth Rate (2015-2020)
Figure 31. Europe Electrocompetent Cells Revenue and Growth Rate (2015-2020)
Figure 32. Asia-Pacific Electrocompetent Cells Revenue and Growth Rate (2015-2020)
Figure 33. South America Electrocompetent Cells Revenue and Growth Rate (2015-2020)
Figure 34. Middle East and Africa Electrocompetent Cells Revenue and Growth Rate (2015-2020)
Figure 35. North America Electrocompetent Cells Revenue Market Share by Countries (2015-2020)
Figure 36. North America Electrocompetent Cells Revenue Market Share by Countries in 2019
Figure 37. USA Electrocompetent Cells Revenue and Growth Rate (2015-2020)
Figure 38. Canada Electrocompetent Cells Revenue and Growth Rate (2015-2020)
Figure 39. Mexico Electrocompetent Cells Revenue and Growth Rate (2015-2020)
Figure 40. Europe Electrocompetent Cells Revenue Market Share by Countries (2015-2020)
Figure 41. Europe Electrocompetent Cells Revenue Market Share by Countries in 2019
Figure 42. Germany Electrocompetent Cells Revenue and Growth Rate (2015-2020)
Figure 43. UK Electrocompetent Cells Revenue and Growth Rate (2015-2020)
Figure 44. France Electrocompetent Cells Revenue and Growth Rate (2015-2020)
Figure 45. Russia Electrocompetent Cells Revenue and Growth Rate (2015-2020)
Figure 46. Italy Electrocompetent Cells Revenue and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Electrocompetent Cells Revenue Market Share by Countries (2015-2020)
Figure 48. Asia-Pacific Electrocompetent Cells Revenue Market Share by Countries in 2019
Figure 49. China Electrocompetent Cells Revenue and Growth Rate (2015-2020)
Figure 50. Japan Electrocompetent Cells Revenue and Growth Rate (2015-2020)
Figure 51. Korea Electrocompetent Cells Revenue and Growth Rate (2015-2020)
Figure 52. India Electrocompetent Cells Revenue and Growth Rate (2015-2020)
Figure 53. Southeast Asia Electrocompetent Cells Revenue and Growth Rate (2015-2020)
Figure 54. South America Electrocompetent Cells Revenue Market Share by Countries (2015-2020)
Figure 55. South America Electrocompetent Cells Revenue Market Share by Countries in 2019
Figure 56. Brazil Electrocompetent Cells Revenue and Growth Rate (2015-2020)
Figure 57. Argentina Electrocompetent Cells Revenue and Growth Rate (2015-2020)
Figure 58. Middle East and Africa Electrocompetent Cells Revenue Market Share by Countries (2015-2020)
Figure 59. Middle East and Africa Electrocompetent Cells Revenue Market Share by Countries in 2019
Figure 60. Saudi Arabia Electrocompetent Cells Revenue and Growth Rate (2015-2020)
Figure 61. UAE Electrocompetent Cells Revenue and Growth Rate (2015-2020)
Figure 62. Egypt Electrocompetent Cells Revenue and Growth Rate (2015-2020)
Figure 63. South Africa Electrocompetent Cells Revenue and Growth Rate (2015-2020)
Figure 64. Global Electrocompetent Cells Revenue Share by Type (2015-2020)
Figure 65. Global Electrocompetent Cells Revenue Share by Type in 2019
Figure 66. Global Electrocompetent Cells Market Share Forecast by Type (2021-2025)
Figure 67. Global Cloned Competent Cells Revenue Growth Rate (2015-2020)
Figure 68. Global Agrobacterium tumefaciens Competent Cells Revenue Growth Rate (2015-2020)
Figure 69. Global Expression Competent Cells Revenue Growth Rate (2015-2020)
Figure 70. Global Electrocompetent Cells Revenue Share by Application (2015-2020)
Figure 71. Global Electrocompetent Cells Revenue Share by Application in 2019
Figure 72. Global Electrocompetent Cells Market Share Forecast by Application (2021-2025)
Figure 73. Global Subcloning & Routine Cloning Revenue Growth Rate (2015-2020)
Figure 74. Global Phage Display Library Construction Revenue Growth Rate (2015-2020)
Figure 75. Global Toxic/Unstable Dna Cloning Revenue Growth Rate (2015-2020)
Figure 76. Global High-Throughput Cloning Revenue Growth Rate (2015-2020)
Figure 77. Global Protein Expression Revenue Growth Rate (2015-2020)
Figure 78. Global Mutagenesis Revenue Growth Rate (2015-2020)
Figure 79. Global Single-Stranded Dna Production Revenue Growth Rate (2015-2020)
Figure 80. Global Bacmid creation Revenue Growth Rate (2015-2020)
Figure 81. Global Cre-lox recombination (PIR1/PIR2) Revenue Growth Rate (2015-2020)
Figure 82. Global Electrocompetent Cells Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 83. Global Electrocompetent Cells Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 84. Global Electrocompetent Cells Revenue Market Share Forecast by Regions (2021-2025)
Figure 85. North America Electrocompetent Cells Revenue Market Forecast (2021-2025)
Figure 86. Europe Electrocompetent Cells Revenue Market Forecast (2021-2025)
Figure 87. Asia-Pacific Electrocompetent Cells Revenue Market Forecast (2021-2025)
Figure 88. South America Electrocompetent Cells Revenue Market Forecast (2021-2025)
Figure 89. Middle East and Africa Electrocompetent Cells Revenue Market Forecast (2021-2025)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel